Core Viewpoint - GRAIL, Inc. is focused on early cancer detection to improve treatment outcomes and will present at the TD Cowen 45th Annual Health Care Conference on March 4, 2025 [1] Company Overview - GRAIL is a healthcare company dedicated to detecting cancer early when it is more likely to be cured [3] - The company utilizes next-generation sequencing, large-scale clinical studies, and advanced machine learning to identify multiple cancer types at earlier stages [3] - GRAIL's platform supports various aspects of cancer care, including multi-cancer early detection, risk stratification, minimal residual disease detection, biomarker subtyping, and monitoring treatment and recurrence [3] - The company is headquartered in Menlo Park, California, with additional locations in Washington, D.C., North Carolina, and the United Kingdom [3]
GRAIL to Present at TD Cowen 45th Annual Health Care Conference